Anu Gore, PhD

Bio:

Anu is a pharmaceutical development leader with more than 25 years of experience taking ophthalmic and parenteral drug products from early candidate selection through commercialization. At Bausch + Lomb, she leads all formulation and process development for Pharmaceutical R&D, overseeing a portfolio from topical ophthalmic products to long-acting and intraocular drug delivery.

Before joining Bausch + Lomb, Anu spent more than 15 years at Allergan, now part of AbbVie. Her roles there included Asset Strategy Leader for Eye Care and Executive Director of Small Molecule Product Development. She led a late-stage eye care program from Phase 2 through pivotal Phase 3 and NDA preparation and continued her work at AbbVie leading its subretinal gene therapy program. She also led CMC teams across more than ten programs and developed ophthalmic emulsions, suspensions and injectable sustained-release formulations. Earlier in her career, she led pre-formulation at Amgen.

Anu is an inventor on more than a dozen issued U.S. patents in ophthalmic drug delivery. She holds a PhD in Pharmaceutics from Rutgers University and a B.S. in Pharmacy from Bombay University.